Long-term transfer factor treatment in severe atopic dermatitis

Area of Science:

• Immunology
• Dermatology
• Allergy Research

Background:

• Severe atopic dermatitis is a chronic inflammatory skin condition.
• Current treatments may have limitations in managing severe cases.
• Transfer factor therapy is an immunomodulatory approach with potential applications.

Purpose of the Study:

• To evaluate the efficacy of transfer factor therapy in patients with severe atopic dermatitis.
• To assess the impact of transfer factor therapy on clinical symptoms and immune parameters.

Main Methods:

• Transfer factor therapy administered over 1.5 years to three severe atopic dermatitis patients.
• Clinical assessments, serum IgE levels, T and B lymphocyte counts monitored.
• In vitro leucocyte migration tests to assess cellular reactivity to PPD.

Main Results:

• Slight clinical improvements observed, including cessation of impetigo attacks and reduced hospitalizations.
• Serum IgE levels remained high, and T and B lymphocyte counts were subnormal throughout treatment.
• Leucocyte migration test showed no significant alteration in cellular reactivity to PPD.
• A serum inhibitory factor for leucocyte migration disappeared during therapy.

Conclusions:

• Transfer factor therapy demonstrated no convincing effect on immune parameters in severe atopic dermatitis.
• No major alterations in the patients' atopic dermatitis status were observed despite treatment.
• Further research is needed to understand the role of transfer factor in immune modulation for atopic conditions.